Cited by 126Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchCellular transport and secretion

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

The Role of SORL1 in Alzheimer’s Disease

Yin, Rui-Hua, Yu, Jin-Tai, Tan, Lan·2015·Molecular Neurobiology

DOI 10.1007/s12035-014-8742-5

Open this paper in CoChat — free account

Abstract

Genetic variation in SORL1 gene, also known as LR11, has been identified to associate with Alzheimer's disease (AD) through replicated genetic studies. As a type I transmembrane protein, SORL1 is composed of several distinct domains and belongs to both the low-density lipoprotein receptor (LDLR) family and the vacuolar protein sorting 10 (VPS10) domain receptor family. The level of SORL1 was found to be decreased in the AD brain which positively correlated with β-amyloid (Aβ) accumulation. Emerging data suggests that SORL1 contributes to AD through various pathways, including emerging as a central regulator of the trafficking and processing of amyloid precursor protein (APP), involvement in Aβ destruction, and interaction with ApoE and tau protein. Primarily, SORL1 interacts with distinct sets of cytosolic adaptors for anterograde and retrograde movement of APP between the trans-Golgi network (TGN) and early endosomes, thereby restricting the delivery of the precursor to endocytic compartments that favor amyloidogenic breakdown. In this article, we review recent epidemiological and genetical findings of SORL1 that related with AD and speculate the possible roles of SORL1 in the progression of this disease. Finally, given the potential contributions of SORL1 to AD pathogenesis, targeting SORL1 might present novel opportunities for AD therapy.

Integrity signals

Registry

Crossref · 10.1007/s12035-014-8742-5

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease
Rogaeva, E., Meng, Y., Lee, J. H., Gu, Y., Kawarai, T., Zou, F., Katayama, T., Baldwin, C. T., Cheng, R., Hasegawa, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1943 · Cited by 1,167
Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein
Andersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655
The sorting receptor for yeast vacuolar carboxypeptidase Y is encoded by the VPS10 gene
Marcusson, E. G., Horazdovsky, B. F., Cereghino, J. L., Gharakhanian, E., & Emr, S. D. (1994) · Cell · doi:10.1016/0092-8674(94)90219-4 · Cited by 439
Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337
Loss of apolipoprotein E receptor LR11 in Alzheimer disease
Scherzer, C. R., Offe, K., Gearing, M., Rees, H. D., Fang, G., Heilman, C. J., Schaller, C., Bujo, H., Levey, A. I., & Lah, J. J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1200 · Cited by 316
Retromer Binds the FANSHY Sorting Motif in SorLA to Regulate Amyloid Precursor Protein Sorting and Processing
Fjorback, A. W., Seaman, M., Gustafsen, C., Mehmedbasic, A., Gokool, S., Wu, C., Militz, D., Schmidt, V., Madsen, P., Nyengaard, J. R., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2272-11.2012 · Cited by 253
Molecular Characterization of a Novel Human Hybrid-type Receptor That Binds the α2-Macroglobulin Receptor-associated Protein
Jacobsen, L., Madsen, P., Moestrup, S. K., Lund, A. H., Tommerup, N., Nykjær, A., Sottrup-Jensen, L., Gliemann, J., & Petersen, C. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31379 · Cited by 253
The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments
Offe, K., Dodson, S. E., Shoemaker, J. T., Fritz, J. J., Gearing, M., Levey, A. I., & Lah, J. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4946-05.2006 · Cited by 245
Identification of a novel conserved sorting motif required for retromer-mediated endosome-to-TGN retrieval
Seaman, M. N. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.009654 · Cited by 244
Epidemiology and Etiology of Alzheimer’s disease: From Genetic to Non- Genetic Factors
Jiang, T., Yu, J., Tian, Y., & Tan, L. (2013) · Current Alzheimer Research · doi:10.2174/15672050113109990155 · Cited by 231
Self-citation

Show all 61 references

Sorted by citations

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
Alzheimer’s Disease: An Updated Overview of Its Genetics
Andrade-Guerrero, J., Santiago-Balmaseda, A., Jeronimo-Aguilar, P., Vargas-Rodríguez, I., Cadena-Suárez, A. R., Sánchez-Garibay, C., Pozo-Molina, G., Méndez-Catalá, C. F., Cardenas-Aguayo, M.-D.-C., Diaz-Cintra, S., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043754 · Cited by 336
The biological pathways of Alzheimer disease: a review
Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 287
Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
Morris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
Noncoding RNAs in Alzheimer's disease
Idda, M. L., Munk, R. B., Abdelmohsen, K., & Gorospe, M. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1463 · Cited by 211
The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
Dourlen, P., Kilinc, D., Malmanche, N., Chapuis, J., & Lambert, J.-C. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02004-0 · Cited by 168
Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine
Eid, A., Mhatre, I., & Richardson, J. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.03.005 · Cited by 164
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 154
Prediction of Alzheimer’s disease using blood gene expression data
Lee, T., & Lee, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-60595-1 · Cited by 146
Long Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders
Aliperti, V., Skonieczna, J., & Cerase, A. (2021) · Non-Coding RNA · doi:10.3390/ncrna7020036 · Cited by 137
Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Seto, M., Weiner, R. L., Dumitrescu, L., & Hohman, T. J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00452-5 · Cited by 135
Alzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123
The role of innate immunity in Alzheimer's disease
Ennerfelt, H. E., & Lukens, J. R. (2020) · Immunological Reviews · doi:10.1111/imr.12896 · Cited by 124
Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants
Hoogmartens, J., Cacace, R., & Broeckhoven, C. V. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12155 · Cited by 109
Alzheimer’s Disease: Etiology, Neuropathology and Pathogenesis
Sheppard, O., & Coleman, M. P. (2020) · Exon Publications eBooks · doi:10.36255/exonpublications.alzheimersdisease.2020.ch1 · Cited by 127
The Role of Selected Bioactive Compounds in the Prevention of Alzheimer’s Disease
Grodzicki, W., & Dziendzikowska, K. (2020) · Antioxidants · doi:10.3390/antiox9030229 · Cited by 102
Cerebral small vessel disease and Alzheimer’s disease
Cai, Z., Wang, C., He, W., Tu, H., Tang, Z., Xiao, M., & Yan, L. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s90871 · Cited by 102
An optimized quantitative proteomics method establishes the cell type‐resolved mouse brain secretome
Tüshaus, J., Müller, S. A., Kataka, E. S., Zaucha, J., Sebastian Monasor, L., Su, M., Güner, G., Jocher, G., Tahirovic, S., Frishman, D., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020105693 · Cited by 88
SORL1 mutations in early- and late-onset Alzheimer disease
Cuccaro, M. L., Carney, R. M., Zhang, Y., Bohm, C., Kunkle, B. W., Vardarajan, B. N., Whitehead, P. L., Cukier, H. N., Mayeux, R., St. George-Hyslop, P., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000116 · Cited by 77
Axonal Transport Defects in Alzheimer’s Disease
Wang, Z., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8810-x · Cited by 92
Self-citation
IL-1β-driven amyloid plaque clearance is associated with an expansion of transcriptionally reprogrammed microglia
Rivera-Escalera, F., Pinney, J. J., Owlett, L., Ahmed, H., Thakar, J., Olschowka, J. A., Elliott, M. R., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1645-7 · Cited by 75
Dysregulation of Rab5‐mediated endocytic pathways in Alzheimer's disease
Xu, W. L., Fang, F., Ding, J., & Wu, C. (2018) · Traffic · doi:10.1111/tra.12547 · Cited by 72
Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer’s Disease
Loeffler, D. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201182 · Cited by 71
Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats
Stefanova, N. A., Muraleva, N. A., Korbolina, E. E., Владимировна, К. Е., Maksimova, K. Y., & Kolosova, N. G. (2014) · Oncotarget · doi:10.18632/oncotarget.2751 · Cited by 66
Regulation of cargo export and sorting at the trans‐Golgi network
Martino, R. D., Sticco, L., & Luini, A. (2019) · FEBS Letters · doi:10.1002/1873-3468.13572 · Cited by 66
Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
Raut, S., Bhalerao, A., Powers, M., Gonzalez, M., Mancuso, S., & Cucullo, L. (2023) · Cells · doi:10.3390/cells12162019 · Cited by 65
Nanoparticle-mediated growth factor delivery systems: A new way to treat Alzheimer's disease
Lauzon, M.-A., Daviau, A., Marcos, B., & Faucheux, N. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.03.024 · Cited by 66
Nucleocytoplasmic Transport: Regulatory Mechanisms and the Implications in Neurodegeneration
Ding, B., & Sepehrimanesh, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084165 · Cited by 68
Construction of Exosome SORL1 Detection Platform Based on 3D Porous Microfluidic Chip and its Application in Early Diagnosis of Colorectal Cancer
Li, P., Chen, J., Chen, Y., Song, S., Huang, X., Yang, Y., Li, Y., Tong, Y., Yan, X., Li, J., et al. (2023) · Small · doi:10.1002/smll.202207381 · Cited by 66
Roles of Non-Coding RNA in Alzheimer’s Disease Pathophysiology
Olufunmilayo, E. O., & Holsinger, R. M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512498 · Cited by 68
Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer’s Disease (AD) and Age-Related Macular Degeneration (AMD)
Zhao, Y., Bhattacharjee, S., Jones, B. M., Hill, J. M., Clément, C., Sambamurti, K., Dua, P., & Lukiw, W. J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8886-3 · Cited by 65
G-Quadruplexes in Neurobiology and Virology: Functional Roles and Potential Therapeutic Approaches
Xu, J., Huang, H., & Zhou, X. (2021) · JACS Au · doi:10.1021/jacsau.1c00451 · Cited by 63
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Cacabelos, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093059 · Cited by 61
Dysregulation of Neuronal Iron Homeostasis as an Alternative Unifying Effect of Mutations Causing Familial Alzheimer’s Disease
Lumsden, A. L., Rogers, J. T., Majd, S., Newman, M., Sutherland, G. T., Verdile, G., & Lardelli, M. T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00533 · Cited by 60
The role of CD2AP in the Pathogenesis of Alzheimer's Disease
Tao, Q.-Q., Chen, Y.-C., & Wu, Z.-Y. (2019) · Aging and disease · doi:10.14336/ad.2018.1025 · Cited by 61
Some promising medicinal plants used in Alzheimer’s disease: an ethnopharmacological perspective
Bordoloi, S., Pathak, K., Devi, M., Saikia, R., Das, J., Kashyap, V. H., Das, D., Ahmad, M. Z., & Abdel‐Wahab, B. A. (2024) · Discover Applied Sciences · doi:10.1007/s42452-024-05811-7 · Cited by 54
Improving causality in microbiome research: can human genetic epidemiology help?
Wade, K. H., & Hall, L. J. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15628.3 · Cited by 65
CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics
Sen, T., & Thummer, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00564-w · Cited by 52
Role of Oxidative Stress, Methionine Oxidation and Methionine Sulfoxide Reductases (MSR) in Alzheimer’s Disease
Chandran, S., & Binninger, D. (2023) · Antioxidants · doi:10.3390/antiox13010021 · Cited by 45
State of Play in Alzheimer’s Disease Genetics
Zhu, J.-B., Tan, C., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170062 · Cited by 44
Self-citation
Late‐life plasma proteins associated with prevalent and incident frailty: A proteomic analysis
Liu, F., Austin, T. R., Schrack, J. A., Chen, J., Walston, J. D., Mathias, R. A., Grams, M. E., Odden, M. C., Newman, A. B., Psaty, B. M., et al. (2023) · Aging Cell · doi:10.1111/acel.13975 · Cited by 41
Astrocytes modulate neurodegenerative phenotypes associated with glaucoma in OPTN(E50K) human stem cell-derived retinal ganglion cells
Gomes, C., VanderWall, K. B., Pan, Y., Lu, X., Lavekar, S. S., Huang, K.-C., Fligor, C. M., Harkin, J., Zhang, C., Cummins, T., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.05.006 · Cited by 39
Golgi fragmentation – One of the earliest organelle phenotypes in Alzheimer’s disease neurons
Haukedal, H., Corsi, G. I., Gadekar, V. P., Doncheva, N. T., Kedia, S., de Haan, N., Chandrasekaran, A., Jensen, P., Schiønning, P., Vallin, S., et al. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1120086 · Cited by 37
Inflammation as a Possible Link Between Dyslipidemia and Alzheimer’s Disease
Oliveira, B. C. D. L., Bellozi, P. M. Q., Reis, H. J., & de Oliveira, A. C. P. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.012 · Cited by 39
G‐quadruplex regulation of neural gene expression
Cave, J. W., & Willis, D. E. (2021) · FEBS Journal · doi:10.1111/febs.15900 · Cited by 37
Cognitive Resilience in Brain Health and Dementia Research
Joshi, M. S., & Galvin, J. E. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220755 · Cited by 47
Long non-coding RNAs in neurodegenerative diseases
Yang, S., Yang, H., Luo, Y., Deng, X., Zhou, Y., & Hu, B. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105096 · Cited by 33
Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to dampen epileptiform activity
Sánchez, R. G., Parrish, R. R., Rich, M. C., Webb, W. M., Lockhart, R. M., Nakao, K., Ianov, L., Buckingham, S. C., Broadwater, D. R., Jenkins, A. J., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.001 · Cited by 34
Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer’s disease
Ahmadi, S., Zobeiri, M., & Bradburn, S. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00564-9 · Cited by 35
Relation between plasma and brain lipids
Wellington, C. L., & Frikke-Schmidt, R. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000291 · Cited by 33
Prion-like Mechanisms in Alzheimer's Disease
Yin, R., Tan, L., Jiang, T., & Yu, J. (2014) · Current Alzheimer Research · doi:10.2174/156720501108140910121425 · Cited by 33
Self-citation
Deep post-GWAS analysis identifies potential risk genes and risk variants for Alzheimer’s disease, providing new insights into its disease mechanisms
Wang, Z., Zhang, Q., Lin, J.-R., Jabalameli, M. R., Mitra, J., Nguyen, N., & Zhang, Z. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-99352-3 · Cited by 29
The gut microbiota links disease to human genome evolution
Quan, Y., Zhang, K., & Zhang, H. (2023) · Trends in Genetics · doi:10.1016/j.tig.2023.02.006 · Cited by 35
Histone acetylation in an Alzheimer’s disease cell model promotes homeostatic amyloid-reducing pathways
Xu, D. C., Sas‐Nowosielska, H., Donahue, G., Huang, H., Pourshafie, N., Good, C. R., & Berger, S. L. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01696-6 · Cited by 35
Specific Modification of Aged Proteasomes Revealed by Tag-Exchangeable Knock-In Mice
Tomita, T., Hirayama, S., Sakurai, Y., Ohte, Y., Yoshihara, H., Saeki, Y., Hamazaki, J., & Murata, S. (2018) · Molecular and Cellular Biology · doi:10.1128/mcb.00426-18 · Cited by 27
Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease
Chib, S., Dutta, B. J., Chalotra, R., Abubakar, M., Kumar, P., Singh, T. G., & Singh, R. (2024) · Phytotherapy Research · doi:10.1002/ptr.8406 · Cited by 24
The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer’s Disease Modeling
Lee, C., Willerth, S. M., & Nygaard, H. B. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101804 · Cited by 24
Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer’s disease
Vilkaite, G., Vogel, J. W., & Mattsson, N. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101735 · Cited by 25
The Role of Retromer in Alzheimer’s Disease
Zhang, Q.-Y., Tan, M., Yu, J., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9366-0 · Cited by 25
Self-citation
Genetic discoveries and advances in late‐onset Alzheimer’s disease
Rezazadeh, M., Hosseinzadeh, H., Moradi, M., Esfahani, B. S., Talebian, S., Parvin, S., & Gharesouran, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28372 · Cited by 23
Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer’s disease
D’Oliveira Albanus, R., Finan, G. M., Brase, L., Sweeney, N., Kim, T. Y., Chen, S., Ryoo, Y., Park, J., Guo, Q., Iyer, A. K., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adx0027 · Cited by 19
Alzheimer’s disease basics: we all should know
Das, S. K. (2025) · Neurological Research · doi:10.1080/01616412.2025.2529560 · Cited by 19
The aldehyde dehydrogenase 2 rs671 variant enhances amyloid β pathology
Wang, X., Wang, J., Chen, Y., Qian, X., Luo, S., Wang, X., Ma, C., & Ge, W. (2024) · Nature Communications · doi:10.1038/s41467-024-46899-0 · Cited by 16
Association between DNA methylation of SORL1 5′-flanking region and mild cognitive impairment in type 2 diabetes mellitus
Yu, Y., Mingjiao, W., Yang, X., Sui, M., Zhang, T., Liang, J., Gu, X., & Wang, X. (2016) · Annales d Endocrinologie · doi:10.1016/j.ando.2016.02.008 · Cited by 19
PSCAN: Spatial scan tests guided by protein structures improve complex disease gene discovery and signal variant detection
Tang, Z.-Z., Sliwoski, G. R., Chen, G., Jin, B., Bush, W. S., Li, B., & Capra, J. A. (2020) · Genome biology · doi:10.1186/s13059-020-02121-0 · Cited by 13
A review of imaging genetics in Alzheimer's disease
Yu, X., Sheng, J., Miao, M., Wang, L., Yang, Z. X., & Huang, H. (2022) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2022.04.017 · Cited by 15
Exploring the Therapeutic Potential of Noncoding RNAs in Alzheimer’s Disease
Tripathi, S., Sharma, Y., & Kumar, D. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665335550241011080252 · Cited by 15
RNA-Seq Mouse Brain Regions Expression Data Analysis: Focus on ApoE Functional Network
Babenko, V. N., Смагин, Д. А., & Kudryavtseva, N. N. (2017) · Berichte aus der medizinischen Informatik und Bioinformatik/Journal of integrative bioinformatics · doi:10.1515/jib-2017-0024 · Cited by 13
Detection of structural-functional coupling abnormalities using multimodal brain networks in Alzheimer’s disease: A comparison of three computational models
Lu, Y., Wang, L.-Y., Murai, T., Wu, J., Liang, D., & Zhang, Z. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103764 · Cited by 14
New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: A unifying cholesterol hypothesis and new therapeutic approach for AD
Yang, X., Yao, K., Zhang, M., Zhang, W., & Zu, H. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111321 · Cited by 12
SORL1 Is Associated with the Risk of Late-Onset Alzheimer’s Disease: a Replication Study and Meta-Analyses
Zhang, C.-C., Wang, H.-F., Tan, M., Wan, Y., Zhang, W., Zheng, Z.-J., Kong, L., Wang, Z., Tan, L., Jiang, T., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9780-y · Cited by 12
Self-citation
Effect of Alzheimer's Disease Risk Variant rs3824968 at SORL1 on Regional Gray Matter Volume and Age-Related Interaction in Adult Lifespan
Huang, C., Liu, M., Kao, H., Chou, K., Yang, A. C., Wang, Y.-H., Chen, T.-R., Tsai, S., & Lin, C. (2016) · Scientific Reports · doi:10.1038/srep23362 · Cited by 12
Genetic Variants Associated With Alzheimer Disease in the 22 Arab Countries
Al-Thani, H. F., Ahmad, M. N., Younes, S. N., & Zayed, H. (2021) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000447 · Cited by 11
A landscape of the genetic and cellular heterogeneity in Alzheimer diseasePreprint
Brase, L., You, S., Albanus, R. D., Del‐Aguila, J. L., Dai, Y., Novotny, B. C., Soriano‐Tárraga, C., Dykstra, T., Fernández, M. V., Budde, J., et al. (2021) · medRxiv · doi:10.1101/2021.11.30.21267072 · Cited by 11
Transethnic analysis identifies SORL1 variants and haplotypes protective against Alzheimer's disease
Zhou, X., Cao, H., Jiang, Y., Chen, Y., Zhong, H., Fu, W. Y., Lo, R. M. N., Wong, B. W. Y., Cheng, E. Y. L., Mok, K. Y., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14214 · Cited by 9
Impact of SORL1 genetic variations on MRI markers in non-demented elders
Yin, R., Initiative, A. D. N., Li, J., Tan, L., Wang, H.-F., Tan, M., Yu, W.-J., Tan, C., Yu, J., & Tan, L. (2016) · Oncotarget · doi:10.18632/oncotarget.9300 · Cited by 8
Self-citation
Insights into the mechanisms of non-coding RNAs’ implication in the pathogenesis of Alzheimer’s disease
Khodayi-Shahrak, M., Khalaj‐Kondori, M., Feizi, M. A. H., & Talebi, M. (2022) · EXCLI journal · doi:10.17179/excli2022-5006 · Cited by 8
Transcriptome Profile in the Mouse Brain of Hepatic Encephalopathy and Alzheimer’s Disease
Kim, Y., Jung, Y. S., & Song, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010675 · Cited by 7
Evaluation of the relationship between SORL1 gene polymorphism and Parkinson's disease in the Chinese population
Wang, Y., Luan, M., Li, X., Jin, J., & Xie, A. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136602 · Cited by 6
Microglia as a Possible Alternative Therapeutic for Dementia
Alavez-Rubio, J. S., & Juárez‐Cedillo, T. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230112 · Cited by 6
De novo resonance assignment of the transmembrane domain of LR11/SorLA in E. coli membranes
Ding, X., Fu, R., & Tian, F. (2019) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2019.106639 · Cited by 6
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Systematic Review on Neurotoxic Implications of Lead-Induced Gene Expression Alterations in the Etiology of Alzheimer’s Disease
Parithathvi, A., Harshitha, P., Mumbrekar, K. D., & Dsouza, H. S. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01613-6 · Cited by 6
Nuts and Their Potential Role in Alzheimer’s Disease
Vaishnavi, G., & Thenmozhi, A. J. (2023) · Nutritional neurosciences · doi:10.1007/978-981-99-0677-2_9 · Cited by 5
Potential molecular mechanisms of tobacco smoke exposure in Alzheimer’s disease
Xie, Y., Yang, M., Wang, H., Chen, Y., Shi, X., Tang, H., & Sun, Q. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149394 · Cited by 6
CellGO: a novel deep learning-based framework and webserver for cell-type-specific gene function interpretation
Li, P., Wei, J., & Zhu, Y. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad417 · Cited by 5
Association between Alzheimer’s disease genes and trajectories of cognitive function decline in Han Chinese in Taiwan
Hsieh, T.-J., Initiative, A. D. N., Lee, W., Liao, Y., Hsu, C., Fang, Y., Chen, T., Lin, Y., Chang, I., Wang, S., et al. (2021) · Aging · doi:10.18632/aging.203204 · Cited by 5
A computational framework for identifying chemical compounds to bind Apolipoprotein E4 for Alzheimer’s disease intervention
Zhai, T., Krass, E., Zhang, F., & Huang, Z. J. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1188430 · Cited by 6
Single-cell RNA sequencing data reveals rewiring of transcriptional relationships in Alzheimer’s Disease associated with risk variantsPreprint
Bouland, G. A., Marinus, K. I., van Kesteren, R. E., Smit, A. B., Mahfouz, A. E., & Reinders, M. J. T. (2023) · medRxiv · doi:10.1101/2023.05.15.23289992 · Cited by 4
Mapping Alzheimer’s Molecular Pathologies in Large-Scale Connectomics Data: A Publicly Accessible Correlative Microscopy ResourcePreprint
Han, X., Li, P. H., Wang, S., Blakely, T. M., Aggarwal, S., Gopalani, B., Sanchez, M., Schalek, R. L., Meirovitch, Y., Lin, Z., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.24.563674 · Cited by 3
APP as an innate injury-response molecule
Olmsted, Z. T., & Sofroniew, M. V. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107361 · Cited by 3
Developing non-invasive molecular markers for early risk assessment of Alzheimer's disease
Sur, T. K., Mondal, T., Noreen, Z., Johnson, J., Nunlee‐Bland, G., Loffredo, C. A., Korba, B. E., Chandra, V., Jana, S. S., Kwabi‐Addo, B., et al. (2025) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2025.100120 · Cited by 3
Improving causality in microbiome research: can human genetic epidemiology help?
Wade, K. H., & Hall, L. J. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15628.2 · Cited by 2
The causal relationship between gut microbiome composition and Alzheimer’s disease: A two-sample Mendelian randomization analysisPreprint
Monaghan, G., Hatcher, C., Anderson, E. L., & Wade, K. H. (2025) · medRxiv · doi:10.1101/2025.08.20.25333769 · Cited by 2
Pharmacological Effects and Molecular Mechanisms of Lignans in the Treatment of Alzheimer’s Disease
Sun, L., Zhu, X., Fan, C., Wang, Y., Chen, Q., Zhang, L., Zhang, Y., & Liu, Y. (2026) · Molecules · doi:10.3390/molecules31152594 · Cited by 1
Efeito da suplementação de ômega 3 isolado ou associado em pacientes com doença de Alzheimer: uma revisão sistemática da literatura científica
dos Santos, C. R. G., & Cardoso, C. K. D. S. (2020) · HU Revista · doi:10.34019/1982-8047.2019.v45.27797 · Cited by 1
A Study of the SORL1 Gene in the Pathogenesis of Late-onset Alzheimer’s Disease by Affecting the Expression of BDNFPreprint
Zhao, M., Liu, J., He, J., Chen, X., Feng, Y., Wang, C., Liu, W., Liu, X., Liu, M., & Hou, D. (2021) · Research Square · doi:10.21203/rs.3.rs-750372/v1 · Cited by 1
IMMUNE AND MOLECULAR CORRELATES OF RESPONSE TO IMMUNOTHERAPY REVEALED BY BRAIN-METASTATIC MELANOMA MODELSPreprint
Lopès, A., Pérez‐Guijarro, E., Gopalan, V., Rappaport, J., Chen, Q., Huang, A., Lam, K. C., Chin, S., Ebersole, J., Wu, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.26.609785 · Cited by 1
An Explainable Cascading Machine Learning Framework for the Multimodal Characterisation of Mild Cognitive Impairment and Dementia Due to Alzheimer’s DiseasePreprint
Pablo, V. G.-D., Herrero-Tudela, M., Maturana-Candelas, A., Crespo, J. P., Pinto, N., & Peña, C. G. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.6445818 · Cited by 1
Nucleic Acid-Based Risk Factors and Biomarkers: A Future Perspective on their Use and Development in Alzheimer’s Disease
Turk, M., & Huentelman, M. J. (2015) · Personalized Medicine · doi:10.2217/pme.15.18

Authors: Yin, R.-H., Yu, J.-T., & Tan, L.
Affiliations: Qingdao University (CN)
Corresponding author: Tan, Lan
ORCID: Yu, Jin-Tai
Tan, Lan
Venue: Molecular Neurobiology
Publisher: Springer Science and Business Media LLC
Published: 2014-05-16
Volume: 51
Issue: 3
Pages: 909-918
ISSN: 0893-7648 (ISSN-L)
1559-1182
DOI: 10.1007/s12035-014-8742-5
OpenAlex: W2064885915
Cited by: 126
References: 61
Citations by year: 2026: 13 · 2025: 9 · 2024: 17 · 2023: 15 · 2022: 8 · 2021: 13 · 2020: 15 · 2019: 9 · 2018: 8 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 4
FWCI: 0.74
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Molecular Neurobiology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
Keywords: SORL1, Alzheimer's disease, genetic association, amyloid precursor protein, amyloid-beta, APP trafficking, apolipoprotein E, tau protein, trans-Golgi network, early endosomes, amyloidogenic processing, disease progression, therapeutic target
MeSH terms: Alzheimer Disease, Animals, Humans, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, LDL-Receptor Related Proteins, Membrane Transport Proteins, Amyloid Precursor Protein Secretases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of SORL1 in Alzheimer’s Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks